18 September 2020PatentsMuireann Bolger

USPTO announces COVID-19 deferred-fee patent application programme

The United States Patent and Trademark Office (USPTO) has unveiled a deferred-fee provisional patent application pilot programme for inventions that combat COVID-19.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Patents

USPTO increases ‘fast-track’ examinations limit to 15,000

27 September 2021 The US Patent and Trademark Office has announced applicants can file for more prioritised examinations following an increase to the annual limit.

Patents

USPTO issues 11 millionth patent

12 May 2021 The US Patent and Trademark Office has issued US patent number 11 million to 4C Medical Technologies for its prosthetic heart valve invention.

Patents

‘Suspect’ China filings driven by govt subsidies and targets, says USPTO

14 January 2021 The exponential growth in trademarks and patents filed in the US from China may be partially fuelled by subsidies by the Chinese government, according to a new report released by the US Patent and Trademark Office.

Tech litigators join Hogan Lovells’ Paris practice from A&O Shearman

How in-house patent pros are ‘enablers of innovation’

Smart IP for startups: how to avoid the common traps

Defending the realm: How a key MoD supplier crafts its IP strategy

How IP firms can champion LGBTQ+ staff beyond Pride 2025

WATCH: Synergy in science—navigating the landscape of pharmaceutical collaborations

AI patent trends signal tomorrow’s technologies

WATCH: Section 112 – Where has the dust settled?

USPTO announces COVID-19 deferred-fee patent application programme

More on this story

Editor's picks

Editor's picks

More articles